: 2017 favored growth investors; U.S. growth stocks returned roughly 29.59%, more than double the 13.19% return of value stocks. 10 High-Risk, High-Reward Stocks to Buy for 2017
The following stocks represented some of the most successful speculative plays for the year:
: Nine of the top ten performing stocks of the year were in the biotech sector. Companies like Vertex Pharmaceuticals (VRTX) (up 97%) and Dynavax Technologies (DVAX) (up 373%) succeeded based on FDA approvals and breakthrough trial data.
: A high-beta tech play that gained 109% due to a surge in demand and pricing for memory chips used in mobile devices and servers. Sector-Specific Risk Profiles
: 2017 favored growth investors; U.S. growth stocks returned roughly 29.59%, more than double the 13.19% return of value stocks. 10 High-Risk, High-Reward Stocks to Buy for 2017
The following stocks represented some of the most successful speculative plays for the year:
: Nine of the top ten performing stocks of the year were in the biotech sector. Companies like Vertex Pharmaceuticals (VRTX) (up 97%) and Dynavax Technologies (DVAX) (up 373%) succeeded based on FDA approvals and breakthrough trial data.
: A high-beta tech play that gained 109% due to a surge in demand and pricing for memory chips used in mobile devices and servers. Sector-Specific Risk Profiles